Back

Current treatment strategies and outcomes in familial dilated cardiomyopathy

17 May 2025 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (1) Dilated Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Pedro Mangas Palma

Sao Joao University Hospital Centre, Porto (Portugal)

7 More presentations in this session

Presentation thumbnail
Myocarditis: basic differences based by electrocardiogram patterns and prognosis in mild cases of myocarditis
Ms G. Ramantauskaite (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Cardiac safety of pharmaceutically manufactured cannabidiol in patients at increased cardiovascular risk
Doctor L. Cooper (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Gender differences in myocardial reverse remodeling after guideline-directed medical therapy in dilated cardiomyopathy
Mr P. Mangas Palma (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Predictors and clinical implications of left ventricular ejection fraction improvement in arrhythmia-induced cardiomyopathy
Mr C. Palacios-Castello (Seville, ES)
Abstract Slides Video
Presentation thumbnail
Acute myocarditis, a hidden disease: trying to describe diagnostic workflows and to predict mid term outcomes
Doctor M. Masetti (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Contemporary heart failure therapy and left ventricular remodeling in patients with familial dilated cardiomyopathy
thumbnail
Congress Presentation
Clinical efficacy of heart failure guideline directed medical therapy in patients with titin-truncating variants-associated dilated cardiomyopathy
thumbnail
Congress Presentation
Comparative outcomes of ischemic and non-ischemic dilated cardiomyopathy in ICD recipients: a 30-Year retrospective analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources